Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy

Current Eye Research

Volumn 35, Issue 4, 2010, Pages 308-313

  Yan, Hua ^a   Cui, Jing ^a   Lu, Yingjuan ^a   Yu, Jinguo ^a   Chen, Song ^a   Xu, Yinghai ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Hemorrhage; Proliferative diabetic retinopathy; Reason; Retreatment; Vitrectomy; Vitreous

Indexed keywords

ANTIBIOTIC AGENT; MYDRIATIC AGENT; SILICONE OIL; STEROID;

ADULT; AGED; ARTICLE; CAPILLARY PROLIFERATION; CILIARY DISK; CORNEA EPITHELIUM; CRYOTHERAPY; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; EYE DISEASE; EYE SYNECHIA; FEMALE; FOLLOW UP; HEALING IMPAIRMENT; HUMAN; HYPOTENSION; INTRAOCULAR PRESSURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); NUCLEUS SCLEROSIS; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; SAFETY; SCLEROTOMY; TREATMENT FAILURE; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; AGED; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETREATMENT; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 77950787146     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903572491     Document Type: Article

References (25)

1. Machemer R, Parel JM, Buettner H. A new concept for vitreous surgery: Instrumentation. Am J Ophthalmol. 1972;74:1022-1033.
2. Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753-759.
3. Yang CM. Surgical treatment for diabetic retinopathy: 5-year experience. J Formos Med Assoc. 1998;97:477-484.
4. Michels RG, Rice TA, Rice EF. Vitrectomy for diabetic vitreous hemorrhage. Am J Ophthalmol. 1983;95:12-21.
5. Brown GC, Tasman WS, Benson WE, et al. Reoperation following diabetic vitrectomy. Arch Ophthalmol. 1992;110:506-510.
6. Blankenship GW. Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. Ophthalmology. 1986;93:39-44.
7. Blumenkranz MS, Gardner T, Blankenship GW. Fluid-gas exchange and photocoagulation after vitrectomy: Indication, technique, and result. Arch Ophthalmol. 1986;104:291-296.
8. Han DP, Murphy ML, Mieler WF, et al. Outpatient airfluid exchange for severe postvitrectomy diabetic vitreous hemorrhage: Long-term results and complications. Retina. 1991;11:309-314.
9. Schachat AP, Oyakawa KT, Michels TG, et al. Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology. 1983;90:522-530.
10. Mieler WF, Wolf MD. Management of postvitrectomy diabetic vitreous hemorrhage. In: Lewis H, Ryan SJ (Eds.). Medical and Surgical Retina: Advances, Controversies, and Management. St. Louis: Mosby, 1994; pp. 330-340.
11. Buettner H, Machemer R. Histopathologic findings in human eyes after pars plana vitrectomy and lensectomy. Arch Ophthalmol. 1977;95:2029-2033.
12. Foos RY, Kreiger AE, Nofsinger K. Pathologic study following vitrectomy for proliferative diabetic retinopathy [case report]. Retina. 1985;5:101-106.
13. Kreiger AE. Wound complications in pars plana vitrectomy. Retina. 1993;13:335-344.
14. Koch FH, Kreiger AE, Spitznas M, et al. Pars plana incisions of four patients: Histopathology and electron microscopy. Br J Ophthalmol. 1995;79:486-493.
15. Ocular Fundus Disease Study Group of Chinese Society of Ophthalmology. Criteria for diabetic retinopathy staging. Chinese J Ocular Fundus Dis. 1985;1:42.
16. Yan H, Han Q, Xu YH, et al. The effect of vitrectomy on blood sugar in patients with diabetes mellitus. Chinese J Ocular Fundus Dis. 2001;17:236.
17. Machemer R, Norton EWD. A new concept of vitreous surgery. 3. Indications and results. Am J Ophthalmol. 1972;74:1034-1056.
18. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: Results of a randomized trial. Report 3. Ophthalmology. 1988;95:1307-1320.
19. Benson WE, Brown GC, Tasman W, et al. Complications of vitrectomy for nonclearing vitreous hemorrhage in diabetic patients. Ophthalmic Surg. 1988;19:862-864.
20. Thompson JT, DeBustros S, Michels RG, et al. Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol. 1987;105:191-195.
21. Yeh PT, Yang CM, Yang CH, et al. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: An ultrasound biomicroscopy study. Ophthalmology. 2005;112:2095-2102.
22. Hotta K, Hirakata A, Ohi Y, et al. Ultrasound biomicroscopy for examination of the sclerotomy site in eyes with proliferative diabetic retinopathy after vitrectomy. Retina. 2000;20:52-58.
23. Bhende M, Agraharam SG, Gopal L, et al. Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage. Ophthalmology. 2000;107:1729-1736.
24. Hershberger VS, Augsburger JJ, Hutchins RK, et al. Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage. Ultrasound biomicroscopy findings. Ophthalmology. 2004;111:1215-1221.
25. Pülborn G, Teichmann KD, Teichmann I. Intraocular fibrous proliferation as an incisional complication in pars plana vitrectomy. Am J Ophthalmol. 1977;83:810-814.